T vector velocity: A new ECG biomarker for identifying drug effects on cardiac ventricular repolarization
W. Bystricky, C. Maier, G. Gintant, D. Bergau, K. Kamradt, P. Welsh, D. Carter
This paper introduces T vector velocity (TVV) as a new ECG biomarker to assess drug effects on cardiac ventricular repolarization, showing improved performance over existing metrics.
bioRxiv · Sep 14, 2018Pharmacology & Toxicology